1. PROLONGED MOLECULAR AND CLINICAL REMISSIONS IN FOLLICULAR LYMPHOMA PATIENTS TREATED WITH HDT/ASCT AND COMBINATION IMMUNOTHERAPY WITH RITUXIMAB AND INTERFERON α. (June 2017) Authors: Berinstein, N.; Smyth, L.; Pennell, N.; Weerasinghe, R.; Cheung, M.; Imrie, K.; Spaner, D.; Chodirker, L.; Piliotis, E.; Milliken, V.; Boudreau, A.; Zhang, L.; Reis, M.; Chesney, A.; Good, D.; Ghorab, Z.; Buckstein, R. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 365 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Rituximab in Lymphoma and Chronic Lymphocytic Leukaemia: A Practice Guideline. Issue 1 (January 2017) Authors: Prica, A.; Baldassarre, F.; Hicks, L.K.; Imrie, K.; Kouroukis, T.; Cheung, M. Journal: Clinical oncology Issue: Volume 29:Issue 1(2017) Page Start: e13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Topic: AS07-Singular Entities/Subtypes/AS07a-ARCH, CCUS, ICUS: THE IMPACT OF CHIP ON CHEMOTHERAPY-RELATED OUTCOMES AND CLONAL DYNAMICS IN OLDER LYMPHOMA PATIENTS. (May 2023) Authors: Buckstein, R.; Cheung, M.; Mozessohn, L.; Chodirker, L.; Imrie, K.; Berinstein, N.; Chow, S.; Lopes, O.; Kupakuwana-Suk, G.; Fu, A.; Mcnaughton, A.; Parmentier, A.; Sasitharakumar, P.; Tsui, H.; Zhang, L.; Rauh, M. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗